Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer

Lim, S; Kim, Y; Lee, SB; Kang, HG; Kim, D; Park, JW; Chung, D; Kong, H; Yoo, KH; Kim, Y; Han, W; Chun, KH; Park, JH

ONCOGENESIS, 2020; 9 (10):

Abstract

Checkpoint kinase 1 (Chk1) expression is enhanced in most cancers owing to oncogenic activation and constant replicative stress. Chk1 inactivation is ......

Full Text Link